Regarding MCI-AD cases in cohort 1, ten of fourteen patients had increased CSF p-tau and decreased Abeta 1-42 (LCN2 mean 101.5 ng/ml); four patients had only increased p-tau (LCN mean: 106 ng/ml). Here, MAPT is linked to Alzheimer disease.